How to Formally Appeal a Specialty Drug Insurance Denial

Your doctor prescribed a specialty medication. Your insurance denied it. The denial letter is three paragraphs of bureaucratic language that essentially says "not medically necessary" — without explaining what evidence they reviewed or what you'd need to prove to get approved.

This is one of the most common and most winnable battles in American healthcare. Here's the complete playbook.

---

Understanding Why Specialty Drugs Get Denied

Before you appeal, you need to know exactly what you're fighting. Specialty drug denials fall into four categories:

Denial Type	What It Means	Best Appeal Strategy
Not medically necessary	Insurer's medical reviewer disagrees with your doctor	Peer-to-peer review + clinical literature
Step therapy required	Must try cheaper drugs first	Document prior failures or contraindications
Not on formulary	Drug isn't on their approved list	Formulary exception request
Prior authorization incomplete	Missing documentation	Resubmit with complete clinical records

---

Step 1: Get the Denial in Writing — Read It Carefully

Call your insurance company and request the written denial notice if you haven't received it. Under federal law (ACA and ERISA), the denial must include:

• The specific reason for denial
• The clinical criteria or plan provisions used to make the decision
• A description of the appeal process
• Your right to request the clinical review criteria used

What to ask for:

"I received a verbal denial for [drug name]. I need the written denial notice with the specific clinical criteria used to make this decision, the name and credentials of the reviewer, and the complete appeal instructions. Please send this to [email/address] within 5 business days."

---

Step 2: Request a Peer-to-Peer Review (Your Doctor's Most Powerful Tool)

The peer-to-peer (P2P) review is the single highest-ROI action in the entire appeal process. Your prescribing physician calls the insurance company's medical reviewer directly and argues the case physician-to-physician.

Why it works: Insurance medical reviewers are often general practitioners reviewing decisions outside their specialty. When a specialist calls and presents current clinical guidelines, the reviewer frequently reverses the denial on the spot.

P2P overturn rates by specialty:

• Oncology drugs: 60–75%
• Rheumatology/biologics: 55–70%
• Neurology: 45–60%
• Psychiatry: 40–55%

What your doctor needs to say to the insurance company:

"I am [Dr. Name], [specialty], treating [patient name] for [diagnosis]. I am requesting an urgent peer-to-peer review of the prior authorization denial for [drug name], denial reference number [#]. I am available [dates/times]. Please have a physician reviewer in [relevant specialty] available for this call."

Key clinical arguments to prepare:

1. Why the denied drug is the standard of care for this patient's specific presentation
2. Why formulary alternatives are contraindicated or have already failed
3. Relevant clinical guidelines (cite the specific guideline and year)
4. Published literature supporting the drug for this indication

---

Step 3: File a Formal Internal Appeal

If P2P doesn't resolve it, file a formal written internal appeal. You have 180 days from the denial date to file under federal law.

Internal Appeal Letter Template:

---

[Date]

[Insurance Company Name] Appeals Department [Address from denial letter]

Re: Formal Appeal of Prior Authorization Denial Member Name: [Your Name] Member ID: [ID] Date of Denial: [Date] Drug Denied: [Drug Name, Dose, Quantity] Denial Reference #: [Number]

Dear Appeals Department:

I am formally appealing the denial of prior authorization for [drug name] for [diagnosis/ICD-10 code], denied on [date].

Grounds for Appeal:

1. Medical Necessity: [Drug name] is medically necessary for my condition. [Prescriber name], [credentials], has determined that [drug name] is the appropriate treatment based on [clinical guidelines, e.g., "2024 ACR guidelines for rheumatoid arthritis recommend biologic therapy after failure of two DMARDs"].

2. Failure of Formulary Alternatives: I have previously tried and failed the following formulary alternatives:

   • [Drug 1]: Tried [dates], discontinued due to [reason]
   • [Drug 2]: Tried [dates], discontinued due to [reason]

3. Contraindication to Alternatives: [If applicable] The formulary alternatives are contraindicated due to [specific medical reason].

Enclosed Documentation:

• Letter of medical necessity from [prescriber name]
• Clinical records documenting prior treatment failures
• Relevant published clinical guidelines
• FDA-approved labeling for [drug name]

I request that this appeal be reviewed by a physician with expertise in [relevant specialty].

If this internal appeal is denied, I will immediately request an external independent review and file a complaint with [the U.S. Department of Labor / my state insurance commissioner].

Please respond within the federally mandated timeframe.

Sincerely, [Your Name] [Contact Information]

---

Step 4: Request an Expedited Appeal for Urgent Cases

If your condition is serious and waiting 30 days for a standard appeal would cause significant harm, request an expedited appeal. Insurers must decide expedited appeals within 72 hours.

"I am requesting an expedited appeal of the denial for [drug name]. My condition is [diagnosis] and delaying treatment poses a significant risk of [specific harm — e.g., disease progression, hospitalization, irreversible organ damage]. My physician [name] can provide documentation of the urgency."

---

Step 5: External Independent Review — Your Final Backstop

If your internal appeal is denied, you have the right to an external independent review by an organization with no financial relationship with your insurer.

For ERISA plans (most employer-sponsored insurance):

• File with the U.S. Department of Labor: dol.gov/agencies/ebsa/about-ebsa/ask-a-question/ask-ebsa
• Phone: 1-866-444-3272

For state-regulated plans (individual/marketplace, small group):

• File with your state insurance commissioner
• Find your state commissioner: naic.org/state_web_map.htm

For Medicare Part D:

• File with your plan's Independent Review Entity (IRE)
• Escalate to the Medicare Appeals Council if needed
• Phone: 1-800-MEDICARE

For Medicaid:

• Request a state fair hearing through your state Medicaid agency

External review overturn rates for specialty drugs: 40–60%

---

The Complete Appeal Timeline

Day	Action
Day 1	Receive denial; request written denial notice with clinical criteria
Day 1–3	Doctor requests peer-to-peer review
Day 3–7	P2P call occurs; document outcome
Day 7–14	File formal internal appeal with complete documentation
Day 14–44	Insurer reviews internal appeal (30-day deadline)
Day 44+	If denied: file external independent review
Day 44–89	External review decision (45-day deadline)

---

Use MedTrack's Insurance Barrier Tools

MedTrack's Insurance Barriers solutions page provides:

• Downloadable appeal letter templates pre-filled for common specialty drugs
• A prior authorization tracker to monitor your appeal status
• Connection to certified patient advocates who specialize in specialty drug appeals
• Medicare Part D formulary exception guides

For Medicare patients, our Medicare coverage tool shows your plan's formulary tier for any drug and identifies which plans cover your medication at a lower tier — so you can switch plans during open enrollment if needed.

---

This article is for informational purposes only and does not constitute legal advice. Appeal rights and timelines vary by plan type and state. Consult a patient advocate or healthcare attorney for complex denials.